Unfocused, wide ranging voluntary redundancies at Te Whatu Ora will further destabilise public health to meet Government imposed spending cuts, the PSA says.
Pharmac is consulting on plans to widen access to empagliflozin, a medicine used in the treatment of chronic heart failure that would benefit more than 18,000 people in the first year of funding
The crisis in Tairāwhiti primary healthcare is another warning of the looming collapse of primary healthcare in New Zealand unless drastic action is taken, says Dr Angus Chambers, Chair of the General Practice Owners Association (GenPro)
The coalition Government is urgently making financial assistance available for survivors of the Lake Alice Psychiatric Hospital Child and Adolescent Unit (the Lake Alice Unit) who are terminally ill
Source
Media release from Erica Stanford, lead coordination minister for the Government’s response to the Royal Commission’s report into historical abuse in state care and in the care of faith-based institutions and Matt Doocey, minister of mental health
The NZ Drug Foundation is warning people not to consume Rinda brand pineapple lollies after a potentially lethal amount of methamphetamine was found in a lolly wrapped in the brand’s packaging
Source
Media release from the New Zealand Drug Foundation
While keeping up with your Covid-19 boosters is still the most effective way to protect yourself in the ongoing pandemic, infectious disease experts say we could get even better public health value from the vaccines
Source
Media release from the Public Health Communication Centre
Health New Zealand is moving forward implementation planning to ensure a small group of cancer patients can take advantage of free early access to the drug Keytruda shortly ahead of Pharmac starting to fund the medication
Source
Statement from Richard Sullivan, chief clinical officer, Te Whatu Ora - Health New Zealand
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes